Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 121


A Feasibility Study to Determine whether Clinical Contrast-Enhanced MRI can Detect Increased Bladder Permeability in Patients with Interstitial Cystitis.

Towner RA, Wisniewski AB, Wu DH, Van Gordon SB, Smith N, North JC, McElhaney R, Aston CE, Shobeiri SA, Kropp BP, Greenwood-Van Meerveld B, Hurst RE.

J Urol. 2015 Aug 22. pii: S0022-5347(15)04676-5. doi: 10.1016/j.juro.2015.08.077. [Epub ahead of print]


Assessment of colon and bladder crosstalk in an experimental colitis model using contrast-enhanced magnetic resonance imaging.

Towner RA, Smith N, Saunders D, Van Gordon SB, Tyler KR, Wisniewski AB, Greenwood-Van Meerveld B, Hurst RE.

Neurogastroenterol Motil. 2015 Nov;27(11):1571-9. doi: 10.1111/nmo.12654. Epub 2015 Aug 24.


Identification of novel drugs to target dormant micrometastases.

Hurst RE, Hauser PJ, You Y, Bailey-Downs LC, Bastian A, Matthews SM, Thorpe J, Earle C, Bourguignon LY, Ihnat MA.

BMC Cancer. 2015 May 14;15:404. doi: 10.1186/s12885-015-1409-4.


Abnormalities in Expression of Structural, Barrier and Differentiation Related Proteins, and Chondroitin Sulfate in Feline and Human Interstitial Cystitis.

Hauser PJ, VanGordon SB, Seavey J, Sofinowski TM, Ramadan M, Abdullah S, Buffington CA, Hurst RE.

J Urol. 2015 Aug;194(2):571-7. doi: 10.1016/j.juro.2015.01.090. Epub 2015 Jan 28.


Contrast enhanced magnetic resonance imaging as a diagnostic tool to assess bladder permeability and associated colon cross talk: preclinical studies in a rat model.

Towner RA, Smith N, Saunders D, Van Gordon SB, Wisniewski AB, Tyler KR, Greenwood-Van Meerveld B, Hurst RE.

J Urol. 2015 Apr;193(4):1394-400. doi: 10.1016/j.juro.2014.10.120. Epub 2014 Nov 14.


Temporal expression of hyaluronic acid and hyaluronic acid receptors in a porcine small intestinal submucosa-augmented rat bladder regeneration model.

Mondalek FG, Fung KM, Yang Q, Wu W, Lu W, Palmer BW, Frimberger DC, Greenwood-Van Meerveld B, Hurst RE, Kropp BP, Lin HK.

World J Urol. 2015 Aug;33(8):1119-28. doi: 10.1007/s00345-014-1403-5. Epub 2014 Sep 25.


Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression.

Bailey-Downs LC, Thorpe JE, Disch BC, Bastian A, Hauser PJ, Farasyn T, Berry WL, Hurst RE, Ihnat MA.

PLoS One. 2014 May 30;9(5):e98624. doi: 10.1371/journal.pone.0098624. eCollection 2014.


Tryptase activation of immortalized human urothelial cell mitogen-activated protein kinase.

Marentette JO, Hauser PJ, Hurst RE, Klumpp DJ, Rickard A, McHowat J.

PLoS One. 2013 Jul 29;8(7):e69948. doi: 10.1371/journal.pone.0069948. Print 2013.


Suppression and activation of the malignant phenotype by extracellular matrix in xenograft models of bladder cancer: a model for tumor cell "dormancy".

Hurst RE, Hauser PJ, Kyker KD, Heinlen JE, Hodde JP, Hiles MC, Kosanke SD, Dozmorov M, Ihnat MA.

PLoS One. 2013 May 24;8(5):e64181. doi: 10.1371/journal.pone.0064181. Print 2013.


Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage "leaky bladder" model of cystitis.

Engles CD, Hauser PJ, Abdullah SN, Culkin DJ, Hurst RE.

Urology. 2012 Feb;79(2):483.e13-7. doi: 10.1016/j.urology.2011.10.010. Epub 2011 Dec 2.


VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG.

Saban MR, Davis CA, Avelino A, Cruz F, Maier J, Bjorling DE, Sferra TJ, Hurst RE, Saban R.

BMC Physiol. 2011 Nov 7;11:16. doi: 10.1186/1472-6793-11-16.


System level changes in gene expression in maturing bladder mucosa.

Dozmorov M, Stone R 2nd, Clifford JL, Sabichi AL, Engles CD, Hauser PJ, Culkin DJ, Hurst RE.

J Urol. 2011 May;185(5):1952-8. doi: 10.1016/j.juro.2010.12.101. Epub 2011 Mar 21.


Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.

Dozmorov MG, Azzarello JT, Wren JD, Fung KM, Yang Q, Davis JS, Hurst RE, Culkin DJ, Penning TM, Lin HK.

BMC Cancer. 2010 Dec 6;10:672. doi: 10.1186/1471-2407-10-672.


Dual sources of vitronectin in the human lower urinary tract: synthesis by urothelium vs. extravasation from the bloodstream.

Zhang D, Hudson AE, Delostrinos CF, Carmean N, Eastman R Jr, Hicks B, Hurst RE, Bassuk JA.

Am J Physiol Renal Physiol. 2011 Feb;300(2):F475-87. doi: 10.1152/ajprenal.00407.2010. Epub 2010 Nov 3.


A comprehensive and universal method for assessing the performance of differential gene expression analyses.

Dozmorov MG, Guthridge JM, Hurst RE, Dozmorov IM.

PLoS One. 2010 Sep 9;5(9). pii: e12657. doi: 10.1371/journal.pone.0012657.


Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

Hauser PJ, Buethe DA, Califano J, Sofinowski TM, Culkin DJ, Hurst RE.

J Urol. 2009 Nov;182(5):2477-82. doi: 10.1016/j.juro.2009.07.013. Epub 2009 Sep 17.


Gene expression profiling of human alveolar macrophages infected by B. anthracis spores demonstrates TNF-alpha and NF-kappab are key components of the innate immune response to the pathogen.

Dozmorov M, Wu W, Chakrabarty K, Booth JL, Hurst RE, Coggeshall KM, Metcalf JP.

BMC Infect Dis. 2009 Sep 10;9:152. doi: 10.1186/1471-2334-9-152.


Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells.

Dozmorov MG, Hurst RE, Culkin DJ, Kropp BP, Frank MB, Osban J, Penning TM, Lin HK.

Prostate. 2009 Jul 1;69(10):1077-90. doi: 10.1002/pros.20960.


Does the biomarker search paradigm need re-booting?

Hurst RE.

BMC Urol. 2009 Feb 27;9:1. doi: 10.1186/1471-2490-9-1.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk